List of Tables
Table 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of VEGF-A Inhibitor
Table 3. Key Players of VEGF-B Inhibitor
Table 4. Key Players of VEGF-C Inhibitor
Table 5. Key Players of VEGF-D Inhibitor
Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2019-2024)
Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2025-2030)
Table 12. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Trends
Table 13. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
Table 14. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints
Table 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players (2019-2024)
Table 18. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2023)
Table 19. Ranking of Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Solution and Service
Table 23. Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2019-2024)
Table 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2025-2030)
Table 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2019-2024)
Table 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2025-2030)
Table 33. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bayer AG Company Detail
Table 49. Bayer AG Business Overview
Table 50. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 51. Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
Table 52. Bayer AG Recent Development
Table 53. F. Hoffmann-La Roche Ltd. Company Detail
Table 54. F. Hoffmann-La Roche Ltd. Business Overview
Table 55. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 56. F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
Table 57. F. Hoffmann-La Roche Ltd. Recent Development
Table 58. Novartis AG Company Detail
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 61. Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
Table 62. Novartis AG Recent Development
Table 63. Regeneron Pharmaceuticals Inc. Company Detail
Table 64. Regeneron Pharmaceuticals Inc. Business Overview
Table 65. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 66. Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
Table 67. Regeneron Pharmaceuticals Inc. Recent Development
Table 68. Sanofi. Company Detail
Table 69. Sanofi. Business Overview
Table 70. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 71. Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024) & (US$ Million)
Table 72. Sanofi. Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type: 2023 VS 2030
Figure 3. VEGF-A Inhibitor Features
Figure 4. VEGF-B Inhibitor Features
Figure 5. VEGF-C Inhibitor Features
Figure 6. VEGF-D Inhibitor Features
Figure 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application: 2023 VS 2030
Figure 9. Oncology Case Studies
Figure 10. Ophthalmology Case Studies
Figure 11. Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region: 2023 VS 2030
Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players in 2023
Figure 16. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2023
Figure 18. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
Figure 20. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
Figure 24. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2019-2030)
Figure 32. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
Figure 40. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2019-2030)
Figure 44. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bayer AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
Figure 48. Novartis AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
Figure 49. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
Figure 50. Sanofi. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed